These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 16304268)
1. Resolution of residual pleural disease according to time course in tuberculous pleurisy during and after the termination of antituberculosis medication. Han DH; Song JW; Chung HS; Lee JH Chest; 2005 Nov; 128(5):3240-5. PubMed ID: 16304268 [TBL] [Abstract][Full Text] [Related]
2. Study to identify incidence and risk factors associated Residual pleural opacity in tubercular pleural effusion. Kumar Rai D; Thakur S Indian J Tuberc; 2021 Jul; 68(3):374-378. PubMed ID: 34099203 [TBL] [Abstract][Full Text] [Related]
3. Factors influencing residual pleural opacity in tuberculous pleural effusion. Kwon JS; Cha SI; Jeon KN; Kim YJ; Kim EJ; Kim CH; Park JY; Jung TH J Korean Med Sci; 2008 Aug; 23(4):616-20. PubMed ID: 18756047 [TBL] [Abstract][Full Text] [Related]
4. [Residual pleural opacity in patients treated for pleural tuberculosis in Yaounde]. Balkissou AD; Pefura-Yone EW; Netong Gamgne M; Endale Mangamba LM; Onana Ngono I; Poka Mayap V; Evouna Mbarga A; Assamba Mpom SA; Kanko NF; Fodjeu G; Tagne Kamdem PE; Fogang D; Kuaban C Rev Pneumol Clin; 2016 Apr; 72(2):115-21. PubMed ID: 26651928 [TBL] [Abstract][Full Text] [Related]
5. Sonographic septation: a predictor of sequelae of tuberculous pleurisy after treatment. Lai YF; Su MC; Weng HH; Wu JT; Chiu CT Thorax; 2009 Sep; 64(9):806-9. PubMed ID: 19497923 [TBL] [Abstract][Full Text] [Related]
6. A study of loculated tuberculous pleural effusions treated with intrapleural urokinase. Cases Viedma E; Lorenzo Dus MJ; González-Molina A; Sanchis Aldás JL Respir Med; 2006 Nov; 100(11):2037-42. PubMed ID: 16580190 [TBL] [Abstract][Full Text] [Related]
8. [Case of tuberculous pleurisy with eosinophilic pleural effusion and hematological eosinophilia]. Kato E; Yamada N; Sugiura T Kekkaku; 2007 May; 82(5):481-5. PubMed ID: 17564128 [TBL] [Abstract][Full Text] [Related]
9. Development of contralateral pleural effusion during chemotherapy for tuberculous pleurisy. Al-Ali MA; Almasri NM Saudi Med J; 2000 Jun; 21(6):574-6. PubMed ID: 11500710 [TBL] [Abstract][Full Text] [Related]
10. [Glucocorticoids in the treatment of tuberculous pleurisy]. Fijałkowski M; Graczyk J Pol Merkur Lekarski; 2003 Sep; 15(87):288-91. PubMed ID: 14679860 [TBL] [Abstract][Full Text] [Related]
11. [The study of intrapleural urokinase in the prevention of pleural thickening and loculated effusions by tuberculous pleurisy]. Ding D; Deng Q; Zhang H Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jan; 24(1):32-4. PubMed ID: 11802936 [TBL] [Abstract][Full Text] [Related]
12. [A clinical study of tuberculous pleurisy]. Miyamoto J; Koga H; Kohno S; Matsuda H; Yoshitomi Y; Miyazaki Y; Kaku M; Miyazaki T; Watanabe K; Oe T Kekkaku; 1992 Jul; 67(7):509-13. PubMed ID: 1434315 [TBL] [Abstract][Full Text] [Related]
13. Tissue inhibitor of metalloproteinase-1 is responsible for residual pleural thickening in pleural tuberculosis. Hwang KE; Shon YJ; Cha BK; Park MJ; Chu MS; Kim YJ; Jeong ET; Kim HR Tohoku J Exp Med; 2015 Apr; 235(4):327-33. PubMed ID: 25854270 [TBL] [Abstract][Full Text] [Related]
14. In-hospital outcome of patients with culture-confirmed tuberculous pleurisy: clinical impact of pulmonary involvement. Shu CC; Wang JT; Wang JY; Lee LN; Yu CJ BMC Infect Dis; 2011 Feb; 11():46. PubMed ID: 21338482 [TBL] [Abstract][Full Text] [Related]